Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Intravenous fluid therapy in children and young people in hospital

NICE guideline
Reference number: NG29
Published: 09 December 2015
Last updated: 11 June 2020

Register as a stakeholder

History

Surveillance consultation

Surveillance consultation
Surveillance review proposal (online version)
Consultation questions (PDF 352 KB)

Published:

03 August 2022
Supporting documentation (MSWord 19 KB)

Published:

03 August 2022
Surveillance review proposal (PDF version) (PDF 371 KB)

Published:

03 August 2022

Surveillance consultation

Surveillance consultation
Consultation questions (PDF 301 KB)

Published:

07 October 2019
Evidence tables (PDF 397 KB)

Published:

07 October 2019
Consultation summary of evidence (Online version)
Consultation summary of evidence (PDF version) (PDF 255 KB)

Published:

07 October 2019
Surveillance review proposal (online version)
Surveillance review proposal (PDF version) (PDF 188 KB)

Published:

07 October 2019
How to submit comments (PDF 284 KB)

Published:

07 October 2019

Stakeholder list updated

Stakeholder list (PDF 107 KB)

Published:

30 September 2019

Consultation comments published

Consultation comments and responses (PDF 793 KB)

Published:

09 December 2015

Equality and health inequalities assessment

Equality impact assessment (PDF 90 KB)

Published:

09 December 2015

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 2.18 MB)

Published:

13 January 2016
Short version of draft guideline (PDF 672 KB)

Published:

13 January 2016
Guideline appendix A (PDF 1.03 MB)

Published:

13 January 2016
Guideline appendix B (PDF 418 KB)

Published:

13 January 2016
Guideline appendix C (PDF 277 KB)

Published:

13 January 2016
Guideline appendix D (PDF 660 KB)

Published:

13 January 2016
Guideline appendix E (PDF 198 KB)

Published:

13 January 2016
Guideline appendix F (PDF 299 KB)

Published:

13 January 2016
Guideline appendix G (PDF 421 KB)

Published:

13 January 2016
Guideline appendix H (PDF 123 KB)

Published:

13 January 2016
Guideline appendix I (PDF 289 KB)

Published:

13 January 2016
Guideline appendix J (PDF 242 KB)

Published:

13 January 2016
Guideline appendix K (PDF 354 KB)

Published:

13 January 2016
Guideline appendix L (PDF 123 KB)

Published:

13 January 2016
Guideline appendix M (PDF 245 KB)

Published:

13 January 2016
Guideline appendix N (PDF 166 KB)

Published:

13 January 2016
Guideline appendix O (PDF 124 KB)

Published:

13 January 2016
Equality impact assessment (PDF 222 KB)

Published:

13 January 2016

Health economic plan

Health economic plan
Health economic plan (PDF 418 KB)

Published:

17 February 2015
Review questions (PDF 30 KB)

Published:

17 February 2015
Search strategies (PDF 286 KB)

Published:

17 February 2015

Guideline development and consultation

List of registered stakeholders (PDF 28 KB)

Published:

01 June 2015

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope
Equality impact assessment (scoping) (PDF 222 KB)

Published:

28 May 2014
Scoping workshop notes (PDF 105 KB)

Published:

25 March 2014
Final scope (PDF 129 KB)

Published:

08 November 2013
Final scope consultation table with responses (PDF 503 KB)

Published:

08 November 2013
Scope consultation information
Draft scope (PDF 86 KB)

Published:

24 July 2013
List of registered stakeholders (PDF 28 KB)

Published:

01 June 2015

Remit

Remit (PDF 10 KB)

Published:

19 November 2012

Stakeholder lists and how to register

List of registered stakeholders (PDF 28 KB)

Published:

01 June 2015

GDG meeting minutes

GDG meeting minutes
GDG 9 minutes 30 October 2014 (PDF 127 KB)

Published:

05 January 2015
GDG 8 minutes 02 September 2014 (PDF 128 KB)

Published:

05 January 2015
GDG 7 minutes 30 july 2014 (PDF 128 KB)

Published:

10 October 2014
GDG 5 minutes 28 july 2014 (PDF 124 KB)

Published:

27 August 2014
GDG 3 minutes 05 march 2014 (PDF 126 KB)

Published:

17 July 2014
GDG 2 minutes 7 January 2014 (PDF 124 KB)

Published:

20 March 2014
GDG 1 minutes 26 November 2013 (PDF 20 KB)

Published:

10 February 2014